NCT07050485
Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery
Enrolling by Invitation
NAAges 18+InterventionalTreatmentUniversity of South FloridaInvestigator-initiated
~30 participants
Updated 2025-12-29 on ClinicalTrials.gov
What's tested:PoZibioInert placebo
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in fecal Shannon Diversity Index (SDI)
Measured over Baseline, 2 weeks after surgery
Conditions
Where it's being run
2 sites across 1 statesFlorida2
Study leadership
- Richard Jacobson, MD · PRINCIPAL_INVESTIGATOR · University of South Florida
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Change in fecal Shannon Diversity Index (SDI)Baseline, 2 weeks after surgery
The SDI is a number that reflects both the variety and balance of bacteria in the sample. A higher number means a more diverse bacterial community. Change in fecal SDI is difference at 2 weeks after surgery and baseline between two groups